BIO-key International Enters Warrant Exercise Agreement; $2.5M Raised

What Happened
BIO-key International, Inc. announced on August 10, 2026 that it entered into a warrant exercise agreement with an existing institutional investor. Under the agreement, 618,334 outstanding warrants (originally issued October 28, 2025) had their exercise price reduced from $10.20 to $4.06 per share. In exchange for exercising those warrants, the investor received new unregistered warrants to purchase up to 1,236,668 shares at $4.06 per share. The company received approximately $2.51 million in gross proceeds. The company agreed to convene a stockholder meeting to approve exercisability of the new warrants and to file a resale registration statement for shares issuable on exercise.

Key Details

• Existing warrants exercised: 618,334 shares; exercise price lowered from $10.20 to $4.06.
• New warrants issued: up to 1,236,668 shares; exercise price $4.06; beneficial ownership cap of 4.99%.
• Gross proceeds to BIO-key: approx. $2.51 million (before placement agent fees and expenses).
• Corporate actions required: company to call a stockholder meeting within 120 days to seek approval for exercisability, file a resale registration statement and use commercially reasonable efforts to have it effective within 90 days. Placement agent Maxim Group LLC to receive a 5.0% cash fee.

Why It Matters
This transaction provides BIO-key with near-term cash to fund working capital and potentially repay part of a secured note, which can help the company meet obligations and operate. However, the new warrants create potential future dilution if exercised (up to 1.24M shares), although exercisability is subject to stockholder approval and a 4.99% ownership cap for the investor. Investors should watch for the upcoming stockholder meeting, the effectiveness of the resale registration statement, and the net proceeds after placement agent fees to understand the full financial impact.